Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
Catarina Macedo‐Silva(University of Bern), Cármen Jerónimo(Universidade do Porto), Margareta P. Correia(Universidade do Porto), Vera Miranda‐Gonçalves(Instituto Português de Oncologia Francisco Gentil), Nuno Tiago Tavares(Instituto Português de Oncologia Francisco Gentil), Daniela Barros‐Silva(Instituto Português de Oncologia Francisco Gentil), João Lobo(Universidade do Porto), Joana Lencart(Instituto Português de Oncologia Francisco Gentil), Ângelo Oliveira(IPO Porto), Lucia Altucci(Biogem)
Cited by 50
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167